See how public and private biotech investors are performing with deal-level returns data, exit proceeds, check sizes and performance metrics for thousands of public and private biotech investors.
Trusted by university endowments, top-tier consulting firms and leading biotech investors.
Analyze portfolio concentration and returns distribution. Which funds returned with a single investment? Which funds hit consistent doubles and triples?
Which investors hold their investments for the long term? Whose AUM has been most impacted by the public market turmoil? Who is still buying?
Analyze fund strategy and competitiveness with valuations and check size data for hundreds of rounds.
Break down fund portfolios by therapeutic area, development stage, location and deal stage.
Details on investment activity since January 2018, including therapeutic area, stage and co-investors.
Biopharma-focused M&A, IPO and venture comps covering hundreds of billions of dollars in investments and exits.
Investment activity and profiles for thousands of investors
Hundreds of private round valuations
Investor check size, fund size, exits, and recent deals
M&A and IPO comps
Deal-level cash-on-cash returns
Public investor profiles: holdings and portfolio summary, IPO investments, portfolio history and holding periods
Public and private investor performance metrics
Custom reporting and csv data
Analyst support and investment diligence (additional fee)
If you are not satisfied with your purchase, let us know within 14 days for a full refund.